Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive occlusion of terminal portions of the internal carotid arteries (ICAs) and their distal branches, which is later accompanied by compensatory recruitment of an abnormal vascular network termed the 'moyamoya' vessels. 1 MMD is a relatively common cause of pediatric stroke, 2,3 which might lead to irreversible and devastating neurological deficits and intellectual impairments if left untreated. Genetic factors have been speculated, because of the high incidence of familial occurrence. Recently, the first MMD susceptibility gene, RNF213, was reported. 4, 5 The c.14576G4A variant of RNF213 is a missense variant that switches arginine to lysine; the variant has been shown to significantly increase the risk of MMD with an odds ratio of 190.8. 4 In addition, c.14576G4A homozygotes exhibit more severe and wider vasculopathy than heterozygotes. 6 Here, we present sibling cases of MMD having homozygous and heterozygous c.14576G4A variant in RNF213, as well as different clinical course and disease severity.
The cases are Japanese siblings born to nonconsanguineous, healthy unaffected parents. They had a brother without MMD (Figure 1a ). Case 1 (proband) is a 21-year-old male. His pregnancy and delivery were unremarkable and he exhibited normal psychomotor development. He had a first history of transient ischemic attack (TIA) associated with left-sided weakness at age 2, and was subsequently diagnosed with MMD. Bilateral encephalo-duro-arterio-synangiosis (EDAS) 7 was performed 2 months after the initial TIA. However, left hemiparesis persisted after surgery. Brain computed tomography (CT) results revealed a low-density area in the territory of right middle cerebral artery (MCA), and the right cerebral hemisphere was atrophic. An older ischemic lesion was also present in the right occipital region. Cerebral angiograms demonstrated that right ICA, MCA and anterior cerebral artery (ACA) were steno-occlusive with a poor moyamoya vascular network. Left ICA, MCA and ACA were also stenotic, but an abundant moyamoya vascular network was observed. Bilateral frontal omental transplantation 8 was performed at age 3. At 5 years of age, TIAs associated with visual disturbance frequently occurred, and bilateral occipital gracilis muscle transplantation 9 was performed. Following surgery, the TIAs disappeared. Intellectual ability was slowly deteriorating. At age 9, his total intelligence quotient (IQ) was 68, verbal IQ was 73 and performance IQ was 68. At age 12, he suffered repetitive TIAs associated with right-sided weakness. A cerebral blood flow study with stable xenon-enhanced CT showed a diffuse decrease, especially in the left cerebral hemisphere (Figure 1b) . A subcutaneous tissue graft, which included a parietal branch of the left superficial temporal artery and a relevant vein, 10 was transplanted in the left parietal lobe, and TIAs subsequently decreased. At present, mild to moderate hemiparesis was observed on both sides. He can perform basic activities of daily living independently, including self-feeding using chopsticks. TIAs associated with bilateral weakness of lower extremities and dysarthria occur less than once a month. Frequent fore-headache remained. Brain magnetic resonance imaging (MRI) obtained at age 21 showed multiple infarctions with brain atrophy, with no gross interval changes since the previous surgery (Figure 1c) , and cerebral angiograms demonstrated bilateral ICA and posterior cerebral artery (PCA) occlusion (Figure 1d) .
Case 2 was an 18-year-old female, who was the younger sister of the proband. Her pregnancy and delivery were unremarkable, and she exhibited normal psychomotor development. Her initial attack occurred as TIA associated with weakness and numbness of the left hand at age 17. On her admission to the neurosurgical clinic, no abnormal neurological findings were observed. Cerebral vasoreactivity to intravenous acetazolamide administration, evaluated by stable xenon-enhanced CT, 11 was decreased in the right hemisphere (Figure 1e ), although brain MRI showed normal findings (Figure 1f ). Cerebral angiograms revealed that the right proximal portion of the MCA (M1) and left proximal portion of the ACA (A1) were stenotic (Figure 1g ). Case 2 was diagnosed with MMD, and right superficial temporal artery-MCA anastomosis 12 was performed 2 months after diagnosis. Then, the TIAs completely disappeared.
Both parents were examined by brain MRI/MR angiography (MRA) during their 20s or 30s, and the unaffected sibling, who was 20 years old at the time of the study, underwent a brain MRI/MRA at the age of 2. Results were normal for all of them.
Following written informed consent, genomic DNA from the affected siblings and unaffected family members was obtained from either peripheral blood leukocytes or saliva. The mutation analysis of RNF213 (GenBank accession number, NM_020914.4) was performed by highresolution melting analysis and direct sequencing. The homozygous c.14576G4A variant in RNF213 was identified in case 1, and the heterozygous variant was identified in case 2 and all other unaffected family members (father, mother and unaffected sibling). No other mutation was identified in the entire RNF213 gene (Figure 1h) . Sibling MMD cases with different RNF213 genotypes S Miyatake et al Several reports on sibling MMD cases have revealed a tendency towards similar onset age and similar clinical courses. 13, 14 These similarities could be due to similar genetic and environmental backgrounds that the siblings share. The present cases, however, were rather atypical. Case 1, a homozygote of c.14576G4A variant, exhibited an early-onset age and rapid disease progress, which resulted in significant neurological deficits. Cerebral angiograms revealed severe and wide distribution of vasculopathy. In contrast, case 2, the heterozygote of the variant, exhibited a relatively late-onset age and mild clinical course without irreversible brain lesions. Vasculopathy of case 2 appeared milder and exhibited more limited distribution than case 1 (Table 1 ). The differences in clinical phenotypes between the siblings could be explained by different genetic backgrounds: one had two copies of the c.14576G4A variant and the other had only one copy. Present cases give us another evidence that clinical phenotypes of MMD are associated with a dose effect of the heterozygous and homozygous c.14576G4A variants of RNF213. This variant might have a much larger impact on MMD phenotype than common variants of other common diseases.
Why there are both heterozygote of this variant with and without MMD is a difficult question, as it is unclear how much risk one would own with this variant. To solve this, we calculated the life-time incidence rate of MMD if one Japanese has the heterozygous c.14576G4A variant. It was reported that heterozygotes were identified in 153/204 (75%) of patients with MMD, and in 5/283
(1.8%) of normal Japanese controls. 6 Annual incidence is estimated at 0.35-0.94 per 100 000 person-years in Japan. 15, 16 Appling the Bayes' theorem with these data, the life-time incidence rate of MMD having heterozygous was calculated to be 1.44-3.77%. It is suggested that the incidence rate of MMD is relatively low if one had the heterozygous variant, whereas incidence rate for homozygotes are extremely high (478%). 6 This also reflects the effect of this variant with the dose effect.
In conclusion, a family with sibling MMD cases having different doses of the RNF213 variant is first described, clearly showing impact of the variant on clinical phenotype even in members with similar genetic background. 
